Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and approve This is in continuation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The company has rescheduled its Board Meeting from May 4th, 2026 to May 7th, 2026 due to unavoidable circumstances. The meeting will still consider and approve the audited standalone and consolidated financial results for Q4 and the year ended March 31st, 2026. The trading window, which was closed in connection with this meeting, will remain closed until 48 hours after the results are declared, in compliance with the Company's Insider Trading Prevention Code.
This is a routine procedural filing with no material impact on shareholders. The rescheduling is minor (3 days) and the financial results release timeline remains largely unchanged.